TABAK, Ö. F. Et Al. 2018. Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infection patients with diabetes mellitus in Turkey. 27th Conference of the Asian Pacific Association for the Study of the Liver (APASL) , (New Delhi, India).

TABAK, Ö. F., YÖRÜK, G., İNCE, N., KURTARAN, B., NAMIDURU, M., ÖZTOPRAK ÇUVALCI, N., ... ÖNLEN, Y.(2018). Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infection patients with diabetes mellitus in Turkey . 27th Conference of the Asian Pacific Association for the Study of the Liver (APASL), New Delhi, India

TABAK, ÖMER Et Al. "Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infection patients with diabetes mellitus in Turkey," 27th Conference of the Asian Pacific Association for the Study of the Liver (APASL), New Delhi, India, 2018

TABAK, ÖMER F. Et Al. "Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infection patients with diabetes mellitus in Turkey." 27th Conference of the Asian Pacific Association for the Study of the Liver (APASL) , New Delhi, India, 2018

TABAK, Ö. F. Et Al. (2018) . "Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infection patients with diabetes mellitus in Turkey." 27th Conference of the Asian Pacific Association for the Study of the Liver (APASL) , New Delhi, India.

@conferencepaper{conferencepaper, author={ÖMER FEHMİ TABAK Et Al. }, title={Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infection patients with diabetes mellitus in Turkey}, congress name={27th Conference of the Asian Pacific Association for the Study of the Liver (APASL)}, city={New Delhi}, country={India}, year={2018}}